Syros Pharmaceuticals (SYRS) Earnings Date, Estimates & Call Transcripts $0.02 -0.01 (-20.00%) As of 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Syros Pharmaceuticals Earnings Summary Latest Q3 Earnings DateOct. 31EstimatedConsensus EPS (Oct. 31) -$0.76 Actual EPS (Oct. 31) -$0.68 Beat By $0.08 Syros Pharmaceuticals released Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.68, which topped the consensus estimate of -$0.76 by $0.08. With a trailing EPS of -$3.03, Syros Pharmaceuticals' earnings are expected to decrease next year, from ($2.94) to ($2.97) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q)Powered by Get Syros Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Syros Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSYRS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SYRS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Syros Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.70-$0.70-$0.70Q2 20251-$0.72-$0.72-$0.72Q3 20251-$0.68-$0.68-$0.68Q4 20251-$0.69-$0.69-$0.69FY 20254($2.79)($2.79)($2.79) Remove Ads Syros Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/31/2024Q3 2024-$0.76-$0.68+$0.08-$1.20--7/31/2024Q2 2024-$0.79-$0.70+$0.09-$0.81--5/14/2024Q1 2024-$0.89-$0.79+$0.10-$1.48$1.30M-3/27/2024Q4 2023-$1.23-$1.19+$0.04-$0.20$2.40M$0.39M11/14/2023Q3 2023-$1.12-$1.35 -$0.23-$1.27$3.90M$3.76M8/8/2023Q2 2023-$1.11-$1.30 -$0.19-$1.30$3.17M$2.83M5/10/2023Q1 2023-$1.12-$0.85+$0.27-$0.85$2.95M$2.95M Syros Pharmaceuticals Earnings - Frequently Asked Questions When did Syros Pharmaceuticals announce their last quarterly earnings? Syros Pharmaceuticals (NASDAQ:SYRS) last announced its quarterly earning data on Thursday, October 31, 2024. Learn more on SYRS's earnings history. Did Syros Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Syros Pharmaceuticals (NASDAQ:SYRS) reported ($0.68) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.08. Learn more on analysts' earnings estimate vs. SYRS's actual earnings. How can I listen to Syros Pharmaceuticals's earnings conference call? The conference call for Syros Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Syros Pharmaceuticals's conference call transcript? The conference call transcript for Syros Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Syros Pharmaceuticals generate each year? Syros Pharmaceuticals (NASDAQ:SYRS) has a recorded annual revenue of $386,000.00. How much profit does Syros Pharmaceuticals generate each year? Syros Pharmaceuticals (NASDAQ:SYRS) has a recorded net income of -$164.57 million. SYRS has generated -$3.03 earnings per share over the last four quarters. What is Syros Pharmaceuticals's EPS forecast for next year? Syros Pharmaceuticals's earnings are expected to decrease from ($2.94) per share to ($2.97) per share in the next year. More Earnings Resources from MarketBeat Related Companies THAR Earnings PTPI Earnings PTIX Earnings QLGN Earnings ELAB Earnings GLMD Earnings ZVSA Earnings PBM Earnings CERO Earnings ENTO Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s Next Remove Ads This page (NASDAQ:SYRS) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYRS Stock Free SYRS Stock Alerts